William Dameshek

From Wikipedia, the free encyclopedia
Jump to: navigation, search
For the radio personality and writer of the same name, see Dave Dameshek.

William Dameshek (1900-1969) was an American hematologist. Trained at Harvard, he was the founder of Blood, the prime core clinical journal of hematology, in 1946. He is also credited with describing the concept of myeloproliferative diseases in 1951. In addition, he participated in the first studies of nitrogen mustard in various hematological malignancies, widely considered the first uses of chemotherapy in malignant diseases. Dr Dameshek was also the first one who described chronic lymphocytic leukemia (CLL), a commom form of leukemia in adults.

Dr. Dameshek served as president of the American Society of Hematology (ASH) in 1964. He made numerous contributions to ASH as well as the field of hematology and was the first editor of its journal Blood. Given Dr. Dameshek's accomplishments, ASH has named the Dameshek Prize in his honor. Each year the Dameshek Prize is awarded to individual who has made an outstanding contribution in hematology.

References[edit]

  • Goodman LS, Wintrobe MM, Dameshek W, Goodman MJ, Gilman A and McLennan MT. Nitrogen mustard therapy. Use of methyl-bis(beta-chloroethyl)amine hydrochloride and tris(beta-chloroethyl)amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia, and certain allied and miscellaneous disorders. J Am Med Assoc 1946;105:475-476. Reprinted in JAMA 1984;251:2255-61. doi:10.1001/jama.251.17.2255 PMID 6368885.

External links[edit]

The American Society of Hematology (http://www.hematology.org/)